EUVIMEDObjevte EUVIMED
Open access

The Digital Therapeutics Real-World Evidence Framework: An Approach for Guiding Evidence-Based Digital Therapeutics Design, Development, Testing, and Monitoring

Meelim Kim iD, Kevin Patrick iD, Camille Nebeker iD, Job Godino iD, Spencer Stein iD, Predrag Klasnja iD, Olga Perski iD, Clare Viglione iD, Aaron Coleman iD, Eric Hekler iD

Journal of Medical Internet Research · 2024-03-05 · 26 · e49208

DOI: 10.2196/49208 ↗

At a glance

Journal article in Journal of Medical Internet Research, published online on 2024-03-05. Written by Meelim Kim and 9 co-authors. Institution: Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, United States. Major MEDLINE topics: Behavior Therapy, Population Health. Cited 42 times so far (Crossref); 133 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NLM NIH HHS, NCATS NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Digital therapeutics (DTx) are a promising way to provide safe, effective, accessible, sustainable, scalable, and equitable approaches to advance individual and population health. However, developing and deploying DTx is inherently complex in that DTx includes multiple interacting components, such as tools to support activities like medication adherence, health behavior goal-setting or self-monitoring, and algorithms that adapt the provision of these according to individual needs that may change over time. While myriad frameworks exist for different phases of DTx development, no single framework exists to guide evidence production for DTx across its full life cycle, from initial DTx development to long-term use. To fill this gap, we propose the DTx real-world evidence (RWE) framework as a pragmatic, iterative, milestone-driven approach for developing DTx. The DTx RWE framework is derived from the 4-phase development model used for behavioral interventions, but it includes key adaptations that are specific to the unique characteristics of DTx. To ensure the highest level of fidelity to the needs of users, the framework also incorporates real-world data (RWD) across the entire life cycle of DTx development and use. The DTx RWE framework is intended for any group interested in developing and deploying DTx in real-world contexts, including those in industry, health care, public health, and academia. Moreover, entities that fund research that supports the development of DTx and agencies that regulate DTx might find the DTx RWE framework useful as they endeavor to improve how DTxcan advance individual and population health.

Subjects

MeSH terms (MEDLINE)

Behavior TherapyPopulation HealthHumansAlgorithmsHealth BehaviorMedication Adherence

Author keywords

accessibledecisiondecision makingdecision-based evidence-makingdevelopmentdigital therapeuticsmedication adherencemonitoringpharmaceuticalspublic healthreal-world datareal-world evidencesafetestingtherapeutics

Authors and institutions

  • Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, United States.
  • Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • The Qualcomm Institute, University of California San Diego, La Jolla, CA, United States.
  • The Design Lab, University of California San Diego, La Jolla, CA, United States.
  • Laura Rodriguez Research Institute, Family Health Centers of San Diego, San Diego, CA, United States.
  • Spiral Health Inc, San Diego, CA, United States.

ORCID profiles: Meelim Kim, Kevin Patrick, Camille Nebeker, Job Godino, Spencer Stein, Predrag Klasnja, Olga Perski, Clare Viglione, Aaron Coleman, Eric Hekler

Funding

  • NCI NIH HHS
  • NLM NIH HHS
  • NCATS NIH HHS

Cite

APA

Kim, M., Patrick, K., Nebeker, C., Godino, J., Stein, S., Klasnja, P., Perski, O., Viglione, C., Coleman, A., & Hekler, E. (2024). The Digital Therapeutics Real-World Evidence Framework: An Approach for Guiding Evidence-Based Digital Therapeutics Design, Development, Testing, and Monitoring. Journal of Medical Internet Research, 26, e49208. https://doi.org/10.2196/49208

Vancouver

Kim M, Patrick K, Nebeker C, Godino J, Stein S, Klasnja P, et al. The Digital Therapeutics Real-World Evidence Framework: An Approach for Guiding Evidence-Based Digital Therapeutics Design, Development, Testing, and Monitoring. Journal of Medical Internet Research. 2024;26:e49208. doi:10.2196/49208

BibTeX
@article{Kim2024,
  author = {Kim, Meelim and Patrick, Kevin and Nebeker, Camille and Godino, Job and Stein, Spencer and Klasnja, Predrag and Perski, Olga and Viglione, Clare and Coleman, Aaron and Hekler, Eric},
  title = {The Digital Therapeutics Real-World Evidence Framework: An Approach for Guiding Evidence-Based Digital Therapeutics Design, Development, Testing, and Monitoring},
  journal = {Journal of Medical Internet Research},
  year = {2024},
  volume = {26},
  pages = {e49208},
  doi = {10.2196/49208}
}
Start for free →